American Oriental Bioengineering Delays Release of its Third Quarter 2011 Financial Results and Earnings Conference Call PR Newswire JERSEY CITY...
American Oriental Bioengineering to Announce Third Quarter 2011 Financial Results on November 8, 2011 -- Company to Hold Conference Call on...
American Oriental Bioengineering, Inc. Submitted Its Plan to Cure Stock Price Deficiency with Respect to NYSE Listing Standard PR Newswire JERSEY...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________ FORM 8-K CURRENT REPORT...
American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard PR...
We reiterate our Neutral recommendation on American Oriental Bioengineering, Inc. (AOB) with a target price of $1.00. The company recently...
American Oriental Bioengineering’s (AOB) second quarter 2011 earnings per share came in at $0.05, lower than the Zacks Consensus Estimate...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly report...
American Oriental Bioengineering Reports Second Quarter 2011 Financial Results PR Newswire NEW YORK, Aug. 9, 2011 NEW YORK, Aug. 9, 2011...
American Oriental Bioengineering to Announce Second Quarter 2011 Financial Results on August 9, 2011 -- Company to Hold Conference Call on August...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.